Mascha Binder

30PUBLICATIONS
146CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)HaematologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 05, 2026
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|Apr 13, 2026
Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia.

Sujal Ghosh, Yuqin Wang, Christoph Schultheiss

|Feb 09, 2026
Cell Therapies and Bispecific Engagers: Redefining Strategies against Checkpoint Resistance.

Heinz Läubli, David König, Marco Donia

|Jan 05, 2026
High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia.

Paul Schmidt-Barbo, Christoph Schultheiss, Annaïse J Jauch

|Apr 16, 2025
Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors.

Andreas Zingg, Reto Ritschard, Helen Thut

|Nov 11, 2024
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy.

Joseph Tintelnot, Lisa Paschold, Eray Goekkurt

Pageof 5

Frequent Collaborators

20 joint publications

Christoph Schultheiß

11 joint publications

Lisa Paschold

8 joint publications

Edith Willscher

4 joint publications

Heinz Läubli